The drug-like inhibitors block the virus from entering the body's respiratory cells—specifically, they target hemagglutinin, a protein on the surface of type A influenza viruses. The findings ...

Influenza is a viral respiratory ... inhibitors, such as baloxavir (Xofluza), are used to alleviate symptoms and reduce complications by targeting specific mechanisms of the influenza virus.

Influenza and some other RNA viruses rely on the Raf/MEK/ERK signaling pathway inside human cells to replicate. Atriva’s lead candidate, ATR-002, is a small-molecule inhibitor of MEK ...

The Centers for Disease Control and Prevention Respiratory Virus Activity Levels website shows that COVID-19, influenza A and respiratory syncytial virus have all been on the upswing since November.

A nationwide surge in flu, COVID-19, RSV and norovirus infections is fueling concerns of a possible virus "quademic." Or is ...

with influenza-related emergency department visits remaining very high across the U.S. The flu continues to drive the most respiratory illness activity and officials warn that flu-related ...

Compound 7, a molecular inhibitor of the influenza virus, interacting with the influenza virus' hemagglutinin protein. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news ...